Daratumumab - Janssen Biotech
At a glance
- Drug Originator Genmab
- Drug Licenced by Janssen Biotech
- Drug Class Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Apoptosis stimulants; Phagocyte stimulants; T lymphocyte stimulants
- USA Patent Applicants JANSSEN BIOTECH
- USA Patents 51
- BLAs 1
- International Patents 134

Disclaimer